相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Glypican-3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment
Fubo Zhou et al.
MEDICINAL RESEARCH REVIEWS (2018)
Biology and function of glypican-3 as a candidate for early cancerous transformation of hepatocytes in hepatocellular carcinoma (Review)
Mauro Montalbano et al.
ONCOLOGY REPORTS (2017)
Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma
Jordi Bruix et al.
GASTROENTEROLOGY (2016)
Assessment of the Clinical Utility of Glypican 3 as a Serum Marker for the Diagnosis of Hepatocellular Carcinoma
Xiaobo Jia et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2016)
Evaluating clinical and prognostic implications of Glypican-3 in hepatocellular carcinoma
Ahmed Omar Kaseb et al.
ONCOTARGET (2016)
The Utility of Astrocyte Elevated Gene-1 in Diagnosing Hepatocellular Carcinoma
Christina Stallworth et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2015)
The emerging role of astrocyte-elevated gene-1 in hepatocellular carcinoma (Review)
Hai Dan Zhu et al.
ONCOLOGY REPORTS (2015)
Biomarkers for the early diagnosis of hepatocellular carcinoma
Nobuhiro Tsuchiya et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Astrocyte elevated gene-1 overexpression in hepatocellular carcinoma: an independent prognostic factor
Hae Il Jung et al.
ANNALS OF SURGICAL TREATMENT AND RESEARCH (2015)
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
et al.
JOURNAL OF HEPATOLOGY (2015)
Astrocyte Elevated Gene-1 as a Novel Clinicopathological and Prognostic Biomarker for Gastrointestinal Cancers: A Meta-Analysis with 2999 Patients
Yihuan Luo et al.
PLOS ONE (2015)
MACC1 Is Related to Colorectal Cancer Initiation and Early-Stage Invasive Growth
Bing Ren et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2013)
Biomarkers for hepatocellular carcinoma: progression in early diagnosis, prognosis, and personalized therapy
Kai Zhu et al.
BIOMARKER RESEARCH (2013)
Prospective validation of an immunohistochemical panel (glypican 3, heat shock protein 70 and glutamine synthetase) in liver biopsies for diagnosis of very early hepatocellular carcinoma
Silvia Tremosini et al.
GUT (2012)
Hepatocellular tumors: Immunohistochemical analyses for classification and prognostication
Regina Cheuk-Lam Lo et al.
CHINESE JOURNAL OF CANCER RESEARCH (2011)
Metadherin Promotes Hepatocellular Carcinoma Metastasis through Induction of Epithelial-Mesenchymal Transition
Kai Zhu et al.
CLINICAL CANCER RESEARCH (2011)
Management of Hepatocellular Carcinoma: An Update
Jordi Bruix et al.
HEPATOLOGY (2011)
CURRENT CONCEPTS Hepatocellular Carcinoma
Hashem B. El-Serag
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Diagnostic value of glypican-3 in serum and liver for primary hepatocellular carcinoma
Hui Liu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Glypican-3 expression is correlated with poor prognosis in hepatocellular carcinoma
Hirofumi Shirakawa et al.
CANCER SCIENCE (2009)
Utility of Glypican-3 and Survivin in Differentiating Hepatocellular Carcinoma From Benign and Preneoplastic Hepatic Lesions and Metastatic Carcinomas in Liver Fine-Needle Aspiration Biopsies
A. Nassar et al.
DIAGNOSTIC CYTOPATHOLOGY (2009)
Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression
Byoung Kwon Yoo et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005
Sean F. Altekruse et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Value of glypican 3 immunostaining in the diagnosis of hepatocellular carcinoma on needle biopsy
Florencia Anatelli et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2008)
Glypican 3 expression in human nonneoplastic, preneoplastic, and neoplastic tissues: A tissue microarray analysis of 4,387 tissue samples
Daniel Baumhoer et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2008)
Distinction of hepatocellular carcinoma from benign hepatic mimickers using glypican-3 and CD34 immunohistochemistry
Wanda M. P. Coston et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
Diagnosis and treatment of hepatocellular carcinoma
Hashem B. El-Serag et al.
GASTROENTEROLOGY (2008)
Utility of glypican-3 in differentiating hepatocellular carcinoma from other primary and metastatic lesions in FNA of the liver: an immunocytochemical study
Saverio Ligato et al.
MODERN PATHOLOGY (2008)
Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma
Alejandro Forner et al.
HEPATOLOGY (2008)
Glypican-3 immunocytochemistry in liver fine-needle aspirates - A novel stain to assist in the differentiation of benign and malignant liver lesions
Dina Kandil et al.
CANCER CYTOPATHOLOGY (2007)
Glypican-3 expression in hepatocellular tumors: diagnostic value for preneoplastic lesions and hepatocellular carcinomas
Xiao Ying Wang et al.
HUMAN PATHOLOGY (2006)
Glypican-3 expression distinguishes small hepatocellular carcinomas from cirrhosis, dysplastic nodules, and focal nodular hyperplasia-like nodules
Louis Libbrecht et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2006)
Diagnostic utility of immunohistochemistry in hepatocellular carcinoma, its variants and their mimics
Aileen Wee
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2006)
HepPar1, MOC-31, pCEA, mCEA and CD10 for distinguishing hepatocellular carcinoma vs. metastatic adenocarcinoma in liver fine needle aspirates
Luoquan Wang et al.
ACTA CYTOLOGICA (2006)
Diagnostic value of HepPar1 pCEA, CD10, and CD34 expression in separating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration cytology
RS Saad et al.
DIAGNOSTIC CYTOPATHOLOGY (2004)
Glypican-3: A novel serum and histochemical marker for hepatocellular carcinoma
M Capurro et al.
GASTROENTEROLOGY (2003)
Glypican-3 is overexpressed in human hepatocellular carcinoma
YK Sung et al.
CANCER SCIENCE (2003)
Immunoreactivity of Hep Par 1 in hepatic and extrahepatic tumors and its correlation with albumin in situ hybridization in hepatocellular carcinoma
S Kakar et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2003)
Identification and cloning of human astrocyte genes displaying elevated expression after infection with HIV-1 or exposure to HIV-1 envelope glycoprotein by rapid subtraction hybridization, RaSH
ZZ Su et al.
ONCOGENE (2002)
Canalicular immunostaining of neprilysin (CD10) as a diagnostic marker for hepatocellular carcinomas
N Borscheri et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2001)
Immunohistochemical analysis of hepatocellular and adenocarcinoma in the liver: MOC31 compares favorably with other putative markers
AI Porcell et al.
MODERN PATHOLOGY (2000)
分享论文
